Article

AJMC® in the Press, January 10, 2020

Author(s):

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

A broadcast by WTAJ referenced a June 2019 contributor post published in The American Journal of Managed Care® (AJMC®). The contributor article, titled “The Deadly Costs of Insulin,” details the significant price increases of insulin treatment, from $14 for 1 vial in 2001 to $275 in 2019.

Philly Voice’s piece, “Men with testicular cancer may only need one round of chemo, study says,” cited an article published on AJMC® titled, “When Less Is More: Halving Chemo Keeps Testicular Cancer at Bay, Study Finds.” The article outlined findings from a study stating that young men who undergo chemotherapy after surgery for testicular cancer may live with side effects for decades.

Dark Daily featured an April 2019 article of AJMC® titled, “As DTC Genetic Testing Grows Among Consumers, Insurers Are Beginning to Get on Board.” The article stated that by 2021, 100 million people will have used a direct-to-consumer genetic test, indicating its growing popularity among healthcare providers and consumers.

A September 2019 article on AJMC® titled, “Physician Shortage Likely to Impact OB/GYN Workforce in Coming Years,” was spotlighted by MedCity News, which reported that a women’s health startup providing care by blending technology and physical clinics has pulled in $45 million to support growth.

Related Videos
Rachel Dalthorp, MD
Rachel Dalthorp, MD
Rachel Dalthorp, MD
Rachel Dalthorp, MD
Dr David Adamson
David Adamson, MD, FRCSC, FACOG, FACS, founder and CEO of ARC Fertility
Adetunji T. Toriola, MD, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo